Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Medtronic
Baxter
McKinsey
Express Scripts

Last Updated: November 12, 2019

DrugPatentWatch Database Preview

Litigation Details for Allergan Inc. v. Apotex Inc. (D. Del. 2007)

See Plans and Pricing

« Back to Dashboard

Allergan Inc. v. Apotex Inc. (D. Del. 2007)

Docket   Start Trial Date Filed 2007-05-21
Court District Court, D. Delaware Date Terminated 2010-10-13
Cause 35:271 Patent Infringement Assigned To Gregory Moneta Sleet
Jury Demand Both Referred To
Parties ALLERGAN INC.; APOTEX CORP.; APOTEX INC.
Patents 4,089,969; 4,382,892; 4,474,787; 5,089,509; 5,202,128; 5,424,078; 5,474,979; 5,688,819; 6,562,873; 6,627,210; 6,673,337
Attorneys A. Sidney Katz; James P. White; Jonathan E. Singer; Kenneth Laurence Dorsney; Michael A. Krol; Richard L. Horwitz; Robert B. Breisblatt; Sherry L. Rollo; Walter J. Kawula; William J. Marsden , Jr.
Link to Docket External link to docket
Small Molecule Drugs cited in Allergan Inc. v. Apotex Inc.

Details for Allergan Inc. v. Apotex Inc. (D. Del. 2007)

Date Filed Document No. Description Snippet Link To Document
2007-05-21 1 Complaint carboxylic acids (Muchowski et al U.S. Pat. No. 4,089,969), olloxacins/ benzoxazine derivatives (Hayakawa…United States Patents Nos. 5,424,078, (“the ’()78 patent”), 6,562,873 (“the ’873 patent”), 6,627,210 (… (“the ’210 patent”), 6,673,337 (“the ’337 patent”), and 6,641,834 (“the ’834 patent”) under 35 U.S.C.…Umted States Patent 1191 1111 Patent Number; 5,424,078 Dziabo et al. [45] Date of Patent: Jun. 13, 1995…United States Patent 1101 Patent No.: US 6,562,873 Bz Olejnik et al. (45) Date of Patent: *May 13, 2003 External link to document
2007-06-25 12 Answer to Counterclaim United States Patents Nos. 5,424,078, (“ the ‘078 patent” ), 6,562,873 (“ the ‘873 patent” ), 6,627,210…United States Patents Nos. 5,424,078, (“ the ‘078 patent” ), 6,562,873 (“ the ‘873 patent” ), 6,627,210…(“ the ‘210 patent” ), 6,673,337 (“ the ‘337 patent” ), and 6,641,834 (“ the ‘834 patent” ). …(“ the ‘210 patent” ), 6,673,337 (“ the ‘337 patent” ), and 6,641,834 (“ the ‘834 patent” ). …(U.S. Patent No. 5,215,991) in view of Beck et al. (U.S. Patent No. 6,358,935); that the Patent Examiner External link to document
2007-05-22 3 Patent/Trademark Report to Commissioner the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,424,078; 6,562,873 B 2; 6,627,210…TRADEMARK 1 5,424,078 06/13/95 … PATENT OR DATE OF PATENT HOLDER OF PATENT OR TRADEMARK… G Other Pleading PATENT OR DATE OF PATENT …REPORT ON THE TO: Director of the U.S. Patent and Trademark Office FILING External link to document
2007-06-11 8 Answer to Complaint United States Patents Nos. 5,424,078, (“the ‘078 patent” , 6,562,873 (“the ‘873 patent”), 6,627,210 (… United States Patents Nos. 5,424,078, (“the ‘078 patent”), 6,562,873 (“the ‘873 patent”), 6,627,2£0 (…United States Patents Nos. 5,424,078, (“the ‘078 patent”), 6,562,873 (“the ‘873 patent”), 18 … (“the ‘210 patent”), 6,673,337 (“the ‘337 patent”), and 6,641,834 (“the ‘834 patent”) under_?)$ U.S.C… (“the ‘210 patent”), 6,673,337 (“the ‘337 patent”), and 6,641,834 (“the ‘834 patent”) under 35 U.S.C. External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Merck
Baxter
Harvard Business School
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.